Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial. [electronic resource]
Producer: 20171002Description: 1062-1068 p. digitalISSN:- 1474-4457
- Adult
- Aged
- Aged, 80 and over
- Aminoisobutyric Acids
- Antiviral Agents -- administration & dosage
- Benzimidazoles -- administration & dosage
- Cyclopropanes
- Drug Therapy, Combination
- Female
- Genotype
- Hepacivirus -- classification
- Hepatitis C -- drug therapy
- Humans
- Lactams, Macrocyclic
- Leucine -- analogs & derivatives
- Liver Cirrhosis -- complications
- Male
- Middle Aged
- Proline -- analogs & derivatives
- Pyrrolidines
- Quinoxalines -- administration & dosage
- Sulfonamides -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.